US-based HistoSonics has secured the first major insurance coverage for its histotripsy system, amid media speculation of a ...

Fujifilm Healthcare Americas has extended its partnership with the National Rural Health Association (NRHA) for three more ...

Engineers at the University of Cincinnati (UC) in the US have developed a ‘lab-on-a-chip’ device for measuring the stress ...

Israeli startup Mentaily has raised $3m in seed financing to advance the development of LIV, a mental health diagnosis and ...

Weill Cornell Medicine has secured a grant of approximately $4m for a trial to assess a new imaging approach in prostate ...

Strokes remain one of the world’s biggest killers. Thrombectomy offers renewed hope, especially when supported by ...

The FDA has granted approval to Teal Health’s at-home vaginal sample self-collection device, Teal Wand, for cervical cancer ...

MicroTransponder has posted one-year follow-up data for its FDA-approved device, two months after securing $65m in Series F ...

The newly combined entity, Paxman AB, will initially focus on commercialisation efforts for Paxman’s limb cryocompression system to prevent or reduce chemotherapy-induced peripheral neuropathy (CIPN).

The at-home use device claims to deliver targeted vibration therapy to the hips and spine areas. Credit: ANN PATCHANAN / Shutterstock. US-based medical technology company Osteoboost Health has ...

The company noted that more than 40 different robotic endo-surgical instrument types are leveraged by the system, catering to various specialties, including cardiac surgery. Credit: Terelyuk / ...